Pavilack M A, Elner V M, Elner S G, Todd R F, Huber A R
Department of Ophthalmology, University of Michigan, Ann Arbor 48105.
Invest Ophthalmol Vis Sci. 1992 Mar;33(3):564-73.
The mechanisms that regulate corneal infiltration by circulating leukocytes in inflammatory diseases are poorly understood. In this study, we investigated the effects of pro-inflammatory cytokines on corneal endothelial (CE) and stromal (CS) expression of intercellular adhesion molecule-1 (ICAM-1), a specialized cell surface glycoprotein that binds the leukocyte function antigen-1 (LFA-1) receptor present on all leukocytes and enhances immune responses. Using specific monoclonal antibody (mAb) to ICAM-1, immunohistochemical staining of intact human corneas resulted in discrete, granular reaction product in CE and CS cells as well as perilimbal vascular endothelium that increased dramatically when exposed to human recombinant interleukin-1-beta (rIL-1 beta), tumor necrosis factor-alpha (rTNF-alpha), and interferon-gamma (rIFN-gamma). Immunoreactive ICAM-1 in CE and CS cells was differentially increased by each of these cytokines. In contrast, immunoreactive endothelial-leukocyte adhesion molecule-1 and vascular cell adhesion molecule-1 were not detected in any CE or CS cells of unstimulated or cytokine-stimulated corneas. In standardized leukocyte adherence assays, neutrophil binding to CE surfaces of whole corneas increased significantly upon exposure to rIL-1 beta, rTNF-alpha, or rIFN-gamma (P less than 0.001). In parallel assays, mAb to ICAM-1 on CE cells or subunits of LFA-1 receptors on leukocytes, but not control mAb, significantly blocked leukocyte binding to unstimulated (P less than 0.01) or rIFN-gamma-stimulated corneas (P less than 0.001). Our results indicate that: (1) ICAM-1 is expressed at low levels on unstimulated CE cells, CS cells, and perilimbal vascular endothelium; (2) ICAM-1 may be augmented differentially in corneal and perilimbal tissue by pro-inflammatory cytokines; and (3) ICAM-1 is a functional ligand mediating corneal-leukocyte binding. Differential expression of ICAM-1 within corneal tissue may regulate keratitic precipitate formation, leukocyte trafficking and accumulation, and localized generation of immune responses.
炎症性疾病中循环白细胞调节角膜浸润的机制目前尚不清楚。在本研究中,我们研究了促炎细胞因子对角膜内皮细胞(CE)和基质细胞(CS)细胞间黏附分子-1(ICAM-1)表达的影响,ICAM-1是一种特殊的细胞表面糖蛋白,可与所有白细胞上存在的白细胞功能抗原-1(LFA-1)受体结合并增强免疫反应。使用针对ICAM-1的特异性单克隆抗体(mAb),对完整的人角膜进行免疫组织化学染色,结果显示在CE细胞、CS细胞以及角膜缘血管内皮细胞中出现离散的颗粒状反应产物,当暴露于重组人白细胞介素-1β(rIL-1β)、肿瘤坏死因子-α(rTNF-α)和干扰素-γ(rIFN-γ)时,这种反应产物会显著增加。这些细胞因子中的每一种都会使CE细胞和CS细胞中的免疫反应性ICAM-1有差异地增加。相比之下,在未刺激或细胞因子刺激的角膜的任何CE或CS细胞中均未检测到免疫反应性内皮细胞-白细胞黏附分子-1和血管细胞黏附分子-1。在标准化的白细胞黏附试验中,暴露于rIL-1β、rTNF-α或rIFN-γ后,中性粒细胞与全角膜CE表面的结合显著增加(P<0.001)。在平行试验中,针对CE细胞上ICAM-1的mAb或白细胞上LFA-1受体的亚基,但不是对照mAb,可显著阻断白细胞与未刺激角膜(P<0.01)或rIFN-γ刺激角膜(P<0.001)的结合。我们的结果表明:(1)ICAM-1在未刺激的CE细胞、CS细胞和角膜缘血管内皮细胞上低水平表达;(2)促炎细胞因子可能会使角膜和角膜缘组织中的ICAM-1有差异地增加;(3)ICAM-1是介导角膜-白细胞结合的功能性配体。角膜组织内ICAM-1的差异表达可能调节角膜后沉着物的形成、白细胞的迁移和聚集以及免疫反应的局部产生。